Paul founded Zero Stage Capital in 1981. He has invested in, been a director of, or advised more than 80 early-stage venture companies over the past 25 years.
At Zero Stage Capital, Paul leads investments primarily in the life sciences. Companies that Paul has helped develop include Lexidata, Inc., Spire Corporation, Xylogics Limited, Pacer Systems, Inc., Collaborative Research Corporation, SystemSoft Corporation, Aseco Corporation, PerSeptive BioSystems, Inc., Matritech, Inc., AD Tech, Inc., Discom, Inc., and Telebit Corporation, all of which have had initial public offerings. He was also involved with Kurzweil Computer Technologies, Inc., which was acquired by Xerox Corporation, SmartFoods, Inc., which was acquired by Frito-Lay, Inc., and Peptimmune, Inc., which was acquired by Genzyme Corporation.
An expert on venture capital formation, Paul was a delegate to the White House Conference on Small Business, served on the SBA Task Force on Small Business and Innovation, which was instrumental in the legislative proposals to create both the Patent Law Reform Act and the Small Business Innovation Research Act. He also served on the SBA Task Force that developed the guidelines for the revised SBIC program, was elected to the Board of Governors of the National Association of Small Business Investment Companies and was a founder and Executive Committee member of the MIT Enterprise Forum.
Prior to starting Zero Stage Capital, he had a major role in organizing and capitalizing the Massachusetts Technology Development Corporation, a quasi-public enterprise, which for the past 25 years has invested in new high-technology ventures in Massachusetts. Earlier in his career, he held various operating positions in Ciba-Geigy Corporation, The Gillette Company and Standby Systems, Inc.
Paul earned a BA from Harvard College, an MBA from Northeastern University, and an Ed.D. (abd) from Boston University.